Pharmafile Logo

Event Logistics

- PMLiVE

IMI aims €130m at medical research’s unanswered questions

Targets for the partnership’s latest funding round including Alzheimer’s

- PMLiVE

Shake-up at GSK could claim antibiotics unit and UK facilities

The firm says its plans, which are expected to lead to 320 job cuts, are not related to Brexit

- PMLiVE

Vertex hits sweet spot with triple cystic fibrosis therapy

The new treatment could benefit up to 90% of patients with CF

- PMLiVE

Cello Health acquires Advantage Healthcare to strengthen its US presence

Biopharmaceutical insight group boosts Cello’s reach

Nabriva Therapeutics appoints new chief commercial officer

Francesco Maria Lavino joins to support commercialisation of its new antibiotic

Perfecting the pharmaceutical pipeline with AI

How AI can transform the way we identify and validate research

- PMLiVE

Biosimilars eat into J&J’s Remicade sales

But its IL-23 inhibitor 'signals better times ahead'

- PMLiVE

Gilead gets OK for three-in-one hep C therapy in US

FDA clears the new product for the most common HCV genotypes

- PMLiVE

Creative effectiveness: international work that works

Creative Director Damien Parsonage explains how the creative department at Blue Latitude Health creates work that resonates with customers and delivers results.

Blue Latitude Health

- PMLiVE

Merck’s new health charity strikes partnership deal with Tanzania

The Merck Foundation will support oncology fellowship programmes for Tanzanian doctors

- PMLiVE

Is it time we stopped talking about adherence?

Delivering a fresh approach to patient care

Sanofi: Wearables are a core part of our digital trials strategy

Pharma firm partners with Parexel on patient sensor work

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links